Consumption of a high calcium mineral water lowers biochemical indices of bone remodeling in postmenopausal women with low calcium intake.

What Was Tested

The paper reports a study of Vitamin D and Parathyroid Hormone, published as a randomized controlled trial.

The aim of the study was to assess the effects of the consumption of a high calcium mineral water (HCaMW) on biochemical indices of bone remodeling in postmenopausal women with low Ca intake.

Who Took Part

By PubMed's age tags, the people studied were older adults, women only.

One hundred eighty healthy women were recruited (mean age: 70.1+/-4.0 years); 152 completed the 6-month trial.

How the Study Was Run

In design terms this was a randomized, double-blind and placebo-controlled study.

Because people in this Vitamin D study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Blinding on both sides kept the participants and researchers unaware of who received Vitamin D.

Some participants received a placebo instead of Vitamin D, giving a reference point.

What Was Measured

Topics PubMed links to this paper include Anthropometry, Biomarkers, Bone Remodeling, Calcium, Dietary, Mineral Waters, Osteoporosis, Postmenopausal and Parathyroid Hormone.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D and Parathyroid Hormone.

The publication is from 2005 (Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA), a journal based in England.

More context: the related Vitamin D, K2, Magnesium and Zinc library page, all human trials.